BRIEF published on 08/06/2025 at 09:57, 1 year 2 months ago Evotec SE to Release First Half-Year Results 2025 Conference Call Drug Discovery Life Sciences Evotec SE Half-year Results
PRESS RELEASE published on 08/06/2025 at 09:52, 1 year 2 months ago Evotec SE to announce first half-year results 2025 on 13 August 2025 Evotec SE to announce first half-year results for 2025 on 13 August 2025 with a conference call to discuss performance. Company focuses on drug discovery and development Conference Call Drug Discovery Evotec SE Half-year Results AI-driven Innovation
BRIEF published on 07/30/2025 at 07:21, 1 year 3 months ago Evotec and Sandoz Advance Partnership with Potential Toulouse Site Sale Strategic Partnership Evotec SE Biologics Manufacturing Sandoz AG Asset-Lighter Model
BRIEF published on 07/30/2025 at 07:19, 1 year 3 months ago Evotec SE and Sandoz AG to Potentially Sell Just – Evotec Biologics Toulouse Site Evotec SE Transaction Terms Sandoz AG Biologics Sale Toulouse Site
PRESS RELEASE published on 07/30/2025 at 07:16, 1 year 3 months ago Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site Evotec and Sandoz agree on potential sale of Just – Evotec Biologics Toulouse site in strategic partnership evolution Strategic Partnership Sale Evotec Sandoz Biologics
PRESS RELEASE published on 07/30/2025 at 07:14, 1 year 3 months ago EQS-Adhoc: Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site Evotec SE and Sandoz AG plan potential sale of Just - Evotec Biologics Toulouse site for $300m in cash with additional technology related consideration. Evotec to retain economic upside Evotec SE Sale Just - Evotec Biologics Toulouse Sandoz AG
BRIEF published on 07/21/2025 at 11:45, 1 year 3 months ago Evotec Adjusts Revenue Guidance for 2025 Profit Guidance Cost Optimization Evotec Revenue Guidance High-margin Technology 2028 Outlook
PRESS RELEASE published on 07/21/2025 at 11:40, 1 year 3 months ago Evotec adjusts revenue guidance and confirms profit guidance anticipating a more profitable revenue mix Evotec SE adjusts revenue guidance for fiscal year 2025, sticking to profit guidance with a focus on high-margin technology license revenues and cost optimization Evotec SE Profit Guidance Cost Optimization Revenue Guidance High-margin Technology
BRIEF published on 07/21/2025 at 11:30, 1 year 3 months ago Evotec SE Lowers Revenue Forecast but Maintains Profit Outlook for 2025 Market Challenges Revenue Guidance Cost Savings Technology Licensing Profit Outlook
PRESS RELEASE published on 07/21/2025 at 11:25, 1 year 3 months ago EQS-Adhoc: Evotec SE adjusts revenue guidance while confirming profit guidance Evotec SE adjusts revenue guidance while confirming profit guidance for fiscal year 2025, citing changes in revenue mix and cost savings Evotec SE Profit Guidance Revenue Guidance Cost Savings Fiscal Year 2025
Published on 10/30/2026 at 23:35, 1 day 11 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 11 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 16 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 19 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 28 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 6 hours 3 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 18 hours 28 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 12 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 12 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 23 hours ago Capital increase through exercise of subscription rights
